Cargando…
Self-Reported Use of Pharmaceuticals Among Patients With Irritable Bowel Syndrome in Primary Care
BACKGROUND: Irritable bowel syndrome (IBS) has an estimated 10%-12% prevalence in industrial countries. Studies from the United States have shown that IBS causes notable financial losses for employers. Due to the lack of pathophysiological markers, only a fraction of the pharmacological management o...
Autores principales: | Faresjo, Ashild, Grodzinsky, Ewa, Johansson, Saga, Wallander, Mari-Ann, Faresjo, Tomas, Timpka, Toomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438291/ https://www.ncbi.nlm.nih.gov/pubmed/19006443 http://dx.doi.org/10.18553/jmcp.2008.14.9.870 |
Ejemplares similares
-
Health-related quality of life of irritable bowel syndrome patients in different cultural settings
por: Faresjö, Åshild, et al.
Publicado: (2006) -
Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care
por: Faresjö, Åshild, et al.
Publicado: (2013) -
Could gastrointestinal disorders differ in two close but divergent social environments?
por: Grodzinsky, Ewa, et al.
Publicado: (2012) -
Symptoms and health experience in irritable bowel syndrome with focus on men
por: Bureychak, Tetyana, et al.
Publicado: (2022) -
More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS - a case–control study in primary care
por: Grodzinsky, Ewa, et al.
Publicado: (2015)